LACOG - Latin American Cooperative Oncology Group

LACOG - Latin American Cooperative Oncology Group LACOG – The Latin American Cooperative Oncology Group – is a non-profit organization dedicated to cancer research.

11/01/2024

We are pleased to share the publication “Challenges and opportunities for sarcoma care and research in Latin America: a position paper from the LACOG sarcoma group” in the The Lancet Regional Health Americas by LACOG Sacroma Group Chair Dr. Roberto Carmagnani Pestana, MD and other authors.

According to Dr. Roberto, LACOG Sarcoma Group recognizes the limited availability of clinical trials and the significant challenges faced by patients with sarcoma in Latin America. Patients face critical obstacles such as delayed diagnosis, inadequate access to specialized care, and socioeconomic disparities. To address these issues, the article propose an ambitious set of recommendations for progress that emphasizes strengthening regional collaboration, expanding clinical trial opportunities, and fostering the development of multidisciplinary sarcoma care teams.

Learn more in the link: https://lnkd.in/dVtwfgQm

22/12/2023

2023 was a year of achievements for LACOG and advances in cancer research in Latin America.

Our purpose of impacting the lives of cancer patients through research only becomes a reality thanks to the commitment and unity of everyone involved.

We thank the investigators, members, research sites and LACOG staff for their work and dedication! We wish you a merry Christmas and a new year full of achievements and unity to everyone!

Happy Holidays and season’s greetings!

Dr. Carlos Barrios, president of LACOG and director at the Oncology Research Center at Hospital São Lucas-PUCRS, is amon...
18/12/2023

Dr. Carlos Barrios, president of LACOG and director at the Oncology Research Center at Hospital São Lucas-PUCRS, is among the 19 most cited Brazilian researchers globally in Highly Cited Researchers 2023, with participation in more than 300 national and international clinical research projects.

Highly Cited Researchers 2023 features scientists who have demonstrated significant influence in their fields of research. Each selected researcher is the author of multiple highly cited articles, which are in the top 1% of citations in their field and year of publication in the Web of Science in the last decade.

Find out more by accessing the article published in the Zero Hora newspaper: https://gauchazh.clicrbs.com.br/tecnologia/noticia/2023/11/conheca-os-cinco-pesquisadores-gauchos-presentes-na-lista-dos-mais-citados-do-mundo-clpbjzcpn002k014iuqqwk3qx.html

The LACOG Gynecological Group together with the GOG Foundation and EVA - Brazilian Group of Gynecological Tumors is recr...
13/12/2023

The LACOG Gynecological Group together with the GOG Foundation and EVA - Brazilian Group of Gynecological Tumors is recruiting patients for the LACOG 0223 I GOG-3073 ROSELLA clinical trial.

The primary objective of the study is to evaluate progression-free survival (PFS) by BICR in patients treated with intermittent regimen of relacorilant in combination nab-paclitaxel compared with patients trated with nab-paclitaxel monotherapy.

Visit our website and learn more: https://lacogcancerresearch.org/studies/clinical-trials/ongoing/lacog-0223-gog-3073-rosella/

From today until December 9th, the 2023 San Antonio Breast Cancer Symposium will take place in Texas, USA. Physicians fr...
05/12/2023

From today until December 9th, the 2023 San Antonio Breast Cancer Symposium will take place in Texas, USA. Physicians from all over the world will be participating in the event with lectures, articles, abstracts and studies on cancer.

In this edition of the meeting, LACOG was honored to have three abstracts selected, which will be presented by our Executive Director, Dr. Gustavo Werutsky and other authors.

We invite everyone who is present at the event to honor these important works, an effort of many investigators around Latin America to describe the current scenario of breast cancer care, challenges and disparities of optimal care in the region.

During the next days, we will follow the presentations and share them on our social networks. Connect with us at this SABCS 2023 special week!

21/11/2023

It is a pleasure to share with you this recent publication “Development of geriatric oncology in Latin America: A report from the Latin American Cooperative Oncology Group”, in the Journal of Geriatric Oncology by Dr. Luciola Pontes and other authors from the LACOG Geriatric Oncology Group.

Patients ages 65 and above represent >50% of patients with cancer in LATAM. This scenario poses a real health emergency, necessitating LA nations to prioritize the development of infrastructure to provide quality care to the increased number of older adults affected by cancer.

Geriatric oncology has increased its reach across the Latin American region in the last five years, highlighting the advances taking place in Brazil, Chile, and Mexico. The need to improve the care of all adults with cancer is clearly a priority in LMIC globally, including Latin America, and policymakers in developing regions should focus on fulfilling the recommendations outlined by the SIOG priorities for the advancement of geriatric oncology, including improving geriatric oncology education, performing routine geriatric assessments as standard of care, and fostering inclusive research for older adults.

Although geriatric oncology has grown exponentially in LATAM over the last five years, there is still a lot of work to be done to fulfill the needs of the growing population of older adults with cancer.

Learn more here: https://www.sciencedirect.com/science/article/pii/S1879406823002394?dgcid=author

20/11/2023

Check out the video by Dr. Gustavo Gössling talking about the abstract “Cancer Clinical Trials: Current Timelines of regulatory approval in Brazil and trends after the COVID-19 pandemic”, presented as a poster at the XXIV SBOC Congress, in Rio de Janeiro, Brazil.

The article highlights some important points, such as ANVISA timelines have slowly improved in the last decade but remain over 200 days; CONEP timelines showed a significant improvement until 2017, remained stable until 2020, and demonstrated significant worsening in 2022.

Prioritization, optimization, and decentralization of ethical evaluation may be alternatives to speed up these processes and further foster clinical research in Brazil.

17/11/2023

Check out the video by Dr. Heloisa Resende talking about the abstract “Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions
from the 4th CURA meeting, São Paulo, 2023”, presented as a poster at the XXIV SBOC Congress, in Rio de Janeiro, Brazil.

A total of 16 experts pointed out achievements as shortening the time of regulatory processes involving Anvisa and CONEP, development of staff training programs, maintenance of the National Program of Oncological Attention (PRONON), and the foundation of qualified centers in North and Northeast Brazilian regions. Participants also highlighted the Brazilian need of being more competitive in the field, which requires optimizing ongoing policies.

The experts agreed that new strategies that allow patients to get clear information regarding participation in clinical trials and physician-directed programs getting further engagement of them are mandatory. Active and consistent reporting of the ongoing initiatives might help to propagate ongoing advances, increasing Brazilian participation in clinical cancer research.

From November 16th to 18th, the XXIV Brazilian Congress of Clinical Oncology takes place in Rio de Janeiro, Brazil. Phys...
16/11/2023

From November 16th to 18th, the XXIV Brazilian Congress of Clinical Oncology takes place in Rio de Janeiro, Brazil. Physicians from across the country will participate in the event, which will feature lectures from national and international speakers, who will discuss the main developments in oncology clinical practice with a special focus on availability and provision of care.

In this edition of the meeting, LACOG was honored to have two abstracts selected, which will be presented by our investigators members. We invite everyone present at the event to support these important works.

Over the next few days, we will follow the presentations and share them on our social networks. Connect with us this special week of the SBOC Congress!

30/10/2023

According to the World Health Organization, breast cancer is currently the most prevalent type among women in Latin America, with more than 210,000 cases diagnosed per year in the region. The month of October was chosen to emphasize awareness about the disease, and LACOG plays a fundamental role in this scenario. Through research, we contribute to the prevention, diagnosis, treatment and understanding of cancer.

Today LACOG has 7 studies focused on breast cancer, which are being carried out in several Latin American countries, with the aim of advancing knowledge and treatment of the disease, improving patients' quality of life.

19/10/2023

Você sabia que agora o site do LACOG tem uma nova página dedicada para os eventos do grupo?

Nessa página você encontrará mais informações sobre todos os congressos, simpósios e webinars promovidos anualmente pelo LACOG, temas abordados, números das últimas edições, organizadores, fotos e muito mais!

Acesse agora e confira essa novidade: https://lacogcancerresearch.org/events/

18/10/2023

Para aqueles que dedicam suas vidas a cuidar da saúde e bem-estar dos outros, neste Dia do Médico, queremos expressar nossa gratidão. Seu compromisso, dedicação e conhecimento são fundamentais para promover uma melhor qualidade de vida para a nossa sociedade.

O LACOG agradece o trabalho de todos os médicos que fazem parte do grupo, e não medem esforços para desenvolver pesquisas que buscam os tratamentos mais eficazes para os pacientes com câncer.

Endereço

Avenida Ipiranga, 6681 – Prédio 99A – Sala 203
Porto Alegre, RS
91530-000

Horário de Funcionamento

Segunda-feira 08:00 - 17:00
Terça-feira 08:00 - 17:00
Quarta-feira 08:00 - 17:00
Quinta-feira 08:00 - 17:00
Sexta-feira 08:00 - 17:00

Telefone

33845334

Site

Notificações

Seja o primeiro recebendo as novidades e nos deixe lhe enviar um e-mail quando LACOG - Latin American Cooperative Oncology Group posta notícias e promoções. Seu endereço de e-mail não será usado com qualquer outro objetivo, e pode cancelar a inscrição em qualquer momento.

Atalhos

Compartilhar

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Categoria

Latin American Cooperative Oncology Group

LACOG – The Latin American Cooperative Oncology Group – is a non-profit organization, founded in 2009 by a group of Latin-American medical oncologists interested in developing clinical research. This is the first multinational cooperative group in Latin America, exclusively dedicated to clinical and translational cancer research. LACOG currently counts on more than 400 investigators members, present in 194 institutions from 16 Latin America countries.